A short squeeze occurs when short-sellers rush to cover their positions on a stock. The sudden rush of buying can quickly push a stock price higher. After a tough market year in 2022, some stocks have built up large short-seller followings, potentially priming the pump for a new wave of short squeezes.
Thursday is a big day for tech earnings as Alphabet, Amazon and Apple all are set to report their quarterly results.
Hanesbrands shares lost nearly a fifth of their value after the apparel maker eliminated its dividend to shore up its balance sheet as sales continue to slump. The company, reporting earnings on Thursday, said it swung to a fourth-quarter loss on a 16% decline in sales during the period, as consumers pulled back in the U.S. and international markets, and retailers cut orders to reduce their inventory positions. Total sales were down 8% in 2022 and are expected to fall again this year, prompting Hanesbrands to push an $8 billion annual sales target back by two years to 2026.
Air Products and Chemicals (APD) delivered earnings and revenue surprises of -3.30% and 3.59%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
In this market, the last thing investors have been rewarding this earnings season is a bottom-line miss vs. expectations of any magnitude. Except if you are Meta.
Honeywell International Inc. (HON) delivered earnings and revenue surprises of 1.20% and 0.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Change doesn't have to be bad.
Dividend investors should consider loading up on these stocks as this could be a good year for both of their businesses.
Brent Thill, Jefferies Equity Research Analyst, analyzes Meta's stock pop after earnings. You can see the full interview here. Key video highlights 00:25 On how Instagram has improved 00:40 On better ad targeting 00:55 On other social platforms 01:30 On the stock move
If you want to know who really controls Bright Green Corporation ( NASDAQ:BGXX ), then you'll have to look at the...
The S&P 500 dipped by 19% in 2022, but stocks still don’t seem cheap to Charlie Munger, Warren Buffett’s billionaire partner at Berkshire Hathaway. “In my whole adult life, I have never hoarded cash, waiting for better conditions,” Munger said in an interview in late 2022. “I’ve just invested in the best thing I could find.” Yet he acknowledged that Berkshire Hathaway is sitting on billions of dollars in cash. The reason isn’t that Buffett and Munger think they can wait for stocks to get even ch
Pfizer (NYSE: PFE) enjoyed a record year in 2022. The big drugmaker's revenue topped $100 billion. Its earnings per share soared 42% to $5.47, which translates to nearly $31.4 billion in profits. Both top- and bottom-line numbers set all-time highs.
Wood’s team identifies 14 distinct technologies they believe will feed off each other.
In our call of the day, LaDuc says cash is the place to be and that investors are "being paid to wait. They're getting very favorable 4.5% on their sitting cash."
Shares of Waste Management (NYSE: WM) slumped after it reported its fiscal year and fourth-quarter earnings. The company fell short of analyst expectations, but Jamie Louko explains why he's still holding on to shares of this stalwart in this episode.
(Bloomberg) -- Most Read from BloombergMerck Covid Drug Linked to New Virus Mutations, Study SaysAdani Crisis Deepens as Stock Rout Hits $108 Billion, Bonds SinkPorsche Blunder Puts $148,000 Sportscar on Sale for Just $18,000Plenty of Americans Are Drinking Bleach, Still for Sale on AmazonGeorgia Wants Russia to Leave Its Land in a Ukraine Peace DealOPEC’s crude output edged lower last month as the group pressed on with an accord to keep global markets in balance.The Organization of Petroleum Ex
The two megabanks that lagged competitors over the course of the bull market run of the past decade, Wells Fargo (NYSE: WFC) and Citigroup (NYSE: C), are outperforming thus far in 2023. Wells Fargo's stock price is up about 13.8% year to date, while Citigroup was up about 14.2%. Wells Fargo, the fourth-largest bank in the U.S. with about $1.9 trillion in total assets under management, has been dogged by regulatory problems over the past several years.
Merck & Co. posted better-than-expected fourth quarter earnings Thursday, thanks in part to impressive sales of its blockbuster cancer treatment Keytruda, but forecast softer near-term profits, sending shares lower in pre-market trading. Merck said adjusted earnings for the three months ending in December came in at $1.62 per share, down 10% from the same period last year but firmly ahead of the Street consensus forecast of $1.54 per share. Group revenues, Merck said, rose 2% to $13.83 billion, against the $13.67 billion tally forecast by analysts that cover the pharma giant.
Verizon (NYSE: VZ) and Ford (NYSE: F) are attracting investors to their robust dividend yields. This video will answer which dividend stock is a better buy for investors looking for passive income. *Stock prices used were the afternoon prices of Jan.
Eli Lilly experienced a "bump in the road" for its newest diabetes treatment, Mounjaro, an analyst said Thursday as LLY stock toppled.